These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 7205610)
1. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo. Casey FB; Abboa-Offei BE; Marretta J J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610 [TBL] [Abstract][Full Text] [Related]
2. Antiallergic properties of SQ 13,847, an orally effective agent. II. Activity in vitro. Free CA; Hall LE J Pharmacol Exp Ther; 1980 Jun; 213(3):437-40. PubMed ID: 6162946 [TBL] [Abstract][Full Text] [Related]
3. The pharmacologic profile of wy-41,195, a new orally effective antiallergic agent. Carlson RP; Dervinis A; DiLuigi JM; Capetola RJ; Rosenthale ME; Lewis AJ Arzneimittelforschung; 1982; 32(12):1546-53. PubMed ID: 6186261 [TBL] [Abstract][Full Text] [Related]
4. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995 [TBL] [Abstract][Full Text] [Related]
5. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models. Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629 [TBL] [Abstract][Full Text] [Related]
6. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions. Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109 [TBL] [Abstract][Full Text] [Related]
7. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases. Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511 [TBL] [Abstract][Full Text] [Related]
8. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals. Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286 [TBL] [Abstract][Full Text] [Related]
9. Anti-allergic properties of pirquinozol (SQ 13,847) an orally effective agent. Evaluation in an anti-IgE-induced pulmonary function model in rats. Casey FB; Abboa-Offei BE J Pharm Pharmacol; 1983 Jun; 35(6):394-6. PubMed ID: 6135784 [No Abstract] [Full Text] [Related]
10. Inhibition of experimental immediate hypersensitivity reactions by a novel xanthone, RU 31156. Miller P; James GW Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):328-39. PubMed ID: 25634 [TBL] [Abstract][Full Text] [Related]
11. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs. Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506 [TBL] [Abstract][Full Text] [Related]
12. Antiallergic activity of picumast dihydrochloride in several animal species. Roesch A; Schaumann W; Wilhelms OH Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354 [TBL] [Abstract][Full Text] [Related]
13. [The search for new antiallergy compounds among a number of coumarin derivatives and the study of their mechanisms of action]. Saraf AS; Simonian AV; Oganesian ET Eksp Klin Farmakol; 1993; 56(2):47-50. PubMed ID: 7688624 [TBL] [Abstract][Full Text] [Related]
14. BL-5255, a tetrazolylpyrimidinone with potent oral antiallergy activity in animals. Siminoff P; Reed FC; Schurig JE; Juby PF Monogr Allergy; 1979; 14():318-23. PubMed ID: 91959 [TBL] [Abstract][Full Text] [Related]
15. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs. Kamei C; Mio M; Izushi K; Kitazumi K; Tsujimoto S; Fujisawa K; Adachi Y; Tasaka K Arzneimittelforschung; 1991 Sep; 41(9):932-6. PubMed ID: 1724600 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917). Evans DP; Thomson DS Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393 [TBL] [Abstract][Full Text] [Related]
17. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on type I allergic reactions. Kohno SW; Murata T; Kinoshita T; Ohata K Arzneimittelforschung; 1986 Nov; 36(11):1619-27. PubMed ID: 2434110 [TBL] [Abstract][Full Text] [Related]
18. Antiallergic properties of an orally effective agent, [[3-(1H-tetrazol-5-yl)-phenyl] amino] oxoacetic acid n-butyl ester. Agata M; Goto H; Tsuriya Y; Tachibana K; Kuroda T Jpn J Pharmacol; 1982 Aug; 32(4):689-97. PubMed ID: 6182323 [TBL] [Abstract][Full Text] [Related]
19. Bronchodilator and antiallergic properties of LA 2851 (2-4-diamino-7-methyl-pyrazolo (1,5-a) 1,3,5-triazine). Junien JL; Guillaume M; Lakatos C; Sterne J Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):313-26. PubMed ID: 7305566 [TBL] [Abstract][Full Text] [Related]
20. Comparison of effects of investigational compounds upon allergic phenomena in rodents in vivo and in human basophils in vitro. Mielens ZE; Magro A Methods Find Exp Clin Pharmacol; 1982; 4(2):111-7. PubMed ID: 6181358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]